While batch process chemistry remains the standard in the pharmaceutical industry, a clear increase in continuous flow processes has emerged over the past decade thanks to the commercialization of preparative flow reactor units. This need for continuous flow manufacturing of active pharmaceutical ingredients and fine chemicals continues to grow as it offers a number of important advantages over traditional batch manufacturing in terms of quality, safety, and sustainability of the overall process.
Ajinomoto Bio-Pharma Services, with over 40 years manufacturing APIs, discusses how their proven expertise and capabilities in handling dangerous chemistries is crucial in ensuring manufacturing safe products while also delivering cost-effective and ecological benefits. A case study will be presented showcasing this as well as the possibilities beyond the chemical reaction.
Key Learning Objectives:
- Continuous flow processes, customization options, and scale up
- Enhanced safety and sustainability when switching to flow processing
- Sustainability benefits of using green chemistries add-ons to the reactor set-up: dealing with toxic, caustic and precious metal waste streams